España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Jesse Hulsing
Goldman Sachs: Newly Public Avalara Shares Hold 30% Upside Potential
From Laggard To Leader: Goldman Initiates Ceridian At Neutral
Goldman Cites Lack Of Competition In Bullish Coupa Software Initiation
From Laggard To Leader: Goldman Initiates Ceridian At Neutral
Goldman Cites Lack Of Competition In Bullish Coupa Software Initiation
Appian's Multiple And Fundamentals Are Mismatched, Goldman Says In Downgrade
Little Upside Seen In Apptio
Appian's Multiple And Fundamentals Are Mismatched, Goldman Says In Downgrade
Little Upside Seen In Apptio
Hortonworks Downgraded By Goldman Sachs On Lofty Estimates
Talend Turns Favorable At Goldman Sachs
Read More...
Jesse Hulsing Recent News
Veeva Systems Upside Already Priced
HubSpot Neutral At Goldman On Slowing Customer Acquisition
Guidewire Software Has 5% Downside
Goldman Sachs Sees Shopify Turning From A 'Tool' To A 'Platform'
Goldman: Intuit's Q4 Results 'Leave Some Meat On The Bone' For Buyers And Sellers
Goldman Sachs Sees Talend As A Key Enterprise Provider, But Questions Operating Model
Goldman Plays Catch Up: Upgrades Netsuite To Neutral, Removes From Sell List
Intuit Makes Goldman Sachs' Conviction Buy List
Goldman On Hortonworks: Big Data Still Has Legs
Tableau Software Is 'Getting Aggressive,' Goldman Expects Earnings Beat
Here's Why Facebook Messenger Should Help Zendesk
Goldman: Tableau's Next Act 'Critical,' LinkedIn Still A Buy
Why Goldman Sachs Is Buying Emerging Software Giants
Goldman Waiting On The Sidelines On Newly Initiated Splunk, Tableau, Marketo And ServiceNow